skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8

Journal Article · · ACS Medicinal Chemistry Letters

SETD8 is a histone H4–K20 methyltransferase that plays an essential role in the maintenance of genomic integrity during mitosis and in DNA damage repair, making it an intriguing target for cancer research. While some small molecule inhibitors for SETD8 have been reported, the structural binding modes for these inhibitors have not been revealed. Using the complex structure of the substrate peptide bound to SETD8 as a starting point, different natural and unnatural amino acid substitutions were tested, and a potent (Ki 50 nM, IC50 0.33 μM) and selective norleucine containing peptide inhibitor has been obtained.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE Office of Science (SC)
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
1397281
Journal Information:
ACS Medicinal Chemistry Letters, Vol. 7, Issue 12; ISSN 1948-5875
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 8 works
Citation information provided by
Web of Science

References (24)

PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription journal February 2012
Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase journal June 2005
Histone H4 Lysine 20 methylation: key player in epigenetic regulation of genomic integrity journal January 2013
Modulation of p53 Function by SET8-Mediated Methylation at Lysine 382 journal August 2007
Histone Lysine Methyltransferase SETD8 Promotes Carcinogenesis by Deregulating PCNA Expression journal May 2012
SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities: SET8 promotes TWIST-induced EMT journal October 2011
SET8 Recognizes the Sequence RHRK 20 VLRDN within the N Terminus of Histone H4 and Mono-methylates Lysine 20 journal June 2005
Nahuoic Acid A Produced by a Streptomyces sp. Isolated From a Marine Sediment Is a Selective SAM-Competitive Inhibitor of the Histone Methyltransferase SETD8 journal December 2012
Small-Molecule Inhibitors of SETD8 with Cellular Activity journal September 2014
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells journal November 2012
Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8 journal July 2014
Structure–activity relationship studies of SETD8 inhibitors journal January 2014
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations journal October 2012
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors journal January 2012
Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a journal January 2014
Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2 journal May 2015
Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152) journal March 2012
Design and Synthesis of Statine-Based Cell-Permeable Peptidomimetic Inhibitors of Human β-Secretase journal April 2003
Constrained Peptides with Target-Adapted Cross-Links as Inhibitors of a Pathogenic Protein-Protein Interaction journal February 2014
A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers journal June 2012
Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide journal May 2016
Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6 journal September 2016
Arginine Topology Controls Escape of Minimally Cationic Proteins from Early Endosomes to the Cytoplasm journal July 2012
Spontaneous Membrane-Translocating Peptides by Orthogonal High-Throughput Screening journal June 2011

Cited By (6)

The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review journal May 2020
Clinically Applicable Inhibitors Impacting Genome Stability journal May 2018
Identification of a peptide inhibitor for the histone methyltransferase WHSC1 journal May 2018
BindingDB Entry 50048027: Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8. dataset January 2018
Inhibitors of Protein Methyltransferases and Demethylases journal March 2017
Examining sterically demanding lysine analogs for histone lysine methyltransferase catalysis journal February 2020

Figures / Tables (7)